PharmaShots | Incisive News in 3 Shots

Subscribe Now

Retinitis Pigmentosa

Coave Signs an Exclusive License Agreement with Théa to Co-Development and Commercialize CTx-PDE6b for PDE6b Associated Retinitis Pigmentosa in EU

Coave Signs an Exclusive License Agreement with Théa to Co-Development and Commercialize CTx-PDE6b for PDE6b Associated Retinitis...

September 17, 2021

ProQR's QR-421a Receives FDA's Rare Pediatric Disease Designation for Retinitis Pigmentosa

ProQR's QR-421a Receives FDA's Rare Pediatric Disease Designation for Retinitis Pigmentosa

January 31, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us